Anti-MMP9 antibody [EP1254] (ab76003)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EP1254] to MMP9
- Suitable for: ICC/IF, WB, IHC-P, Flow Cyt
- Reacts with: Rat, Human, Recombinant fragment
Overview
-
Product name
Anti-MMP9 antibody [EP1254]
See all MMP9 primary antibodies -
Description
Rabbit monoclonal [EP1254] to MMP9 -
Host species
Rabbit -
Specificity
Based on our preliminary data, ab76003 detects no or weak band of interest in the untreated cell lines at the dilution of 1/200. Treatment increasing the expression of MMP-9 is recommended when using this antibody. -
Tested Applications & Species
See all applications and species dataApplication Species Flow Cyt HumanICC/IF HumanIHC-P HumanRecombinant fragmentWB RatHumanRecombinant fragment -
Immunogen
Synthetic peptide within Human MMP9 aa 100-200. The exact sequence is proprietary.
Database link: P14780 -
Positive control
- WB: U937, HL60 and TPA treated HT1080 cell lysates and rat kidney tissue lysate. IHC-P: Human gastic adenocarcinoma and spleen tissue. ICC/IF: U-2 OS and domoic acid-treated U87-MG cells. Flow Cyt: A431 cells.
-
General notes
This antibody works better in 1% SDS Hot Lysates in WB. For Lysate preparation protocol, please refer to the protocol book in the protocol section and/or here (downloadable copy).
Mouse: We have internal testing data to indicate this antibody reacts with this species in immunohistochemical and ELISA-based applications, but we were unable to detect a band with mouse lysates in western blot. Please contact us for more information.
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
We are constantly working hard to ensure we provide our customers with best in class antibodies. As a result of this work we are pleased to now offer this antibody in purified format. We are in the process of updating our datasheets. The purified format is designated 'PUR' on our product labels. If you have any questions regarding this update, please contact our Scientific Support team.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle. -
Dissociation constant (KD)
KD = 1.58 x 10 -10 M Learn more about KD -
Storage buffer
pH: 7.20
Preservative: 0.01% Sodium azide
Constituents: PBS, 40% Glycerol, 0.05% BSA -
Concentration information loading...
-
Purity
Protein A purified -
Clonality
Monoclonal -
Clone number
EP1254 -
Isotype
IgG -
Research areas
Images
-
All lanes : Anti-MMP9 antibody [EP1254] (ab76003) at 1.5 µg/ml
Lane 1 : Control U937 at 100 µg
Lane 2 : Stimulated U937 (24 hours with 10 ng x mL-1 PMA (ab120297), 3 final hours with 3 ug x mL-1 of Brefeldin (ab120299)) at 100 µg
Lane 3 : Human tonsils at 20 µg
Secondary
All lanes : Goat anti-rabbit at 1/10000 dilution
Predicted band size: 78 kDa
Observed band size: 89 kDa why is the actual band size different from the predicted?Running buffer: MOPS.
Conditions: Denatured/reduced.
This blot was produced using a 4-12% Bis-Tris gel under the MOPS buffer system. The gel was run at 200V for 60 minutes before being transferred onto a nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour before being incubated with ab76003 (rabbit-anti MMP9; 1.5 ug/mL) and ab8245 (loading control to GAPDH; 0.1 ug/mL) for 48 hours at 4°C. Before imaging, antibody binding was detected using infrared-labeled goat anti-rabbit (green) and goat anti-mouse (red) at 1:10,000 dilution for 1 hour at room temperature.
-
Representitive images for skin wound tissue stained for MMP9.
The effect of diabetes on granulation tissue MMP-9 was also studied in a skin excisional wound model. For these studies, the rats were anaesthetized and the dorsum was prepared for wounding. Four full-thickness circular wounds (8mm2) were then created on the dorsum using a biopsy punch as previously described. Wound area was traced daily for determination of wound healing rate (calculated as change in wound area /day) and at day 6 post wounding the animals (n = 5-6/group) were euthanized and the skin containing the wound tissue was excised. Two wounds were snap frozen in liquid N2 for later measurement of gene expression and the other wounds were divided in half and fixed in formalin (10%) for histological and immunohistological studies or frozen in OCT for immunofluorescence staining.
Results are from control (CON) diabetic (DM) and insulin treated DM (DM+INS) animals.
For full image please see paper.
-
All lanes : Anti-MMP9 antibody [EP1254] (ab76003) at 1/200 dilution (purified)
Lane 1 : LoVo (Human colorectal adenocarcinoma epithelial cell) whole cell lysate
Lane 2 : Huh7 (Human hepatocellular carcinoma epithelial cell) whole cell lysate
Lane 3 : MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysate
Lane 4 : HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate
Lane 5 : Caco-2 (Human colorectal adenocarcinoma epithelial cell) whole cell lysate
Lane 6 : A549 (Human lung carcinoma epithelial cell) serum starved overnight whole cell lysate
Lane 7 : A549 (Human lung carcinoma epithelial cell) serum starved overnight, then treated with 80nM TPA for 24 hours whole cell lysate
Lane 8 : MDA-MB-231 (Human breast adenocarcinoma epithelial cell) serum starved overnight whole cell lysate
Lane 9 : MDA-MB-231 (Human breast adenocarcinoma epithelial cell) serum starved overnight, then treated with 200nM TPA for 24 hours whole cell lysate
Lane 10 : HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/20000 dilution
Predicted band size: 78 kDa
Observed band size: 84-82 kDa why is the actual band size different from the predicted?
Exposure time: 60 secondsBlocking and dilution buffer: 5% NFDM/TBST.
The expression of MMP-9 can be stimulated by various agents, such as inflammatory cytokine, growth factor, and 12-O-tetradecanoylphorbol-13-acetate (TPA) (PMID:21047770, 28969043).
Based on our preliminary data, ab76003 detects no or weak band of interest in the untreated cell lines at the dilution of 1/200. Treatment increasing the expression of MMP-9 is recommended when using this antibody.
-
All lanes : Anti-MMP9 antibody [EP1254] (ab76003) at 1/5000 dilution
Lanes 1-2 : HTB94 (human chondrosarcoma cell line) cell lysate
Lanes 3-4 : HTB94 (human chondrosarcoma cell line) conditioned media
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : Goat anti-rabbit IgG at 1/5000 dilution
Developed using the ECL technique.
Predicted band size: 78 kDa
-
Anti-MMP9 antibody [EP1254] (ab76003) at 1/1000 dilution (purified) + Rat kidney tissue lysate at 10 µg
Secondary
Peroxidase-conjugated goat anti-rabbit IgG, (H+L) at 1/1000 dilution
Predicted band size: 78 kDa
Observed band size: 84-92 kDa why is the actual band size different from the predicted?Blocking and dilution buffer: 5% NFDM/TBST.
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human spleen tissue labeling MMP9 with purified ab76003 at 1/1000. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051, an HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500).
Negative control using PBS instead of primary antibody (inset).
Counterstained with hematoxylin.
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human gastric adenocarcinoma tissue labeling MMP9 with unpurified ab76003 at a dilution of 1/100.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
-
Immunocytochemistry/Immunofluorescence analysis of U-2 OS (human osteosarcoma) cells labeling MMP9 with ab76003 at 1/500 (4.3 μg/mL). Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000, 2 μg/mL) was used as the secondary antibody. Cells were counterstained with ab195889 Anti-Alpha Tubulin antibody [DM1A] (1/200, 2.5 μg/mL) - Microtubule Marker (Alexa Fluor® 594). DAPI (blue) was used as a nuclear counterstain.
Confocal image showing cytoplasmic staining onU-2 OS cells, the expression increased after treatment with TPA (200 nM) for 24 hours (middle panel).
Secondary Only Control: PBS was used instead of the primary antibody as the negative control with both TPA treated and untreated U-2 OS cells.
-
Unpurified ab76003 staining MMP9 in U87-MG cells treated with domoic acid (ab120338), by ICC/IF. Increase of MMP9 expression correlates with increased concentration of domoic acid, as described in literature.
The cells were incubated at 37°C for 6h in media containing different concentrations of ab120338 (domoic acid) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with unpurified ab76003 (1/200) dilution was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight® 488 anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue. -
Overlay histogram showing permeabilized A431 (Human epidermoid carcinoma cell line) cells stained with unpurified ab76003 (pink line).
Negative control antibody (green line) was rabbit IgG.
-
All lanes : Anti-MMP9 antibody [EP1254] (ab76003) at 1.5 µg/ml
All lanes :Recombinant Human MMP9 protein (Proenzyme) (ab82955)
Lysates/proteins at 0.1 µg per lane.
Secondary
All lanes : Goat anti-rabbit at 1/10000 dilution
Predicted band size: 78 kDa
Observed band size: 89 kDa why is the actual band size different from the predicted?Running buffer: MOPS.
Conditions: Denatured/reduced.
This blot was produced using a 4-12% Bis-Tris gel under the MOPS buffer system. The gel was run at 200V for 60 minutes before being transferred onto a nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour before being incubated with ab76003 (rabbit-anti MMP9; 1.5 ug/mL) for 48 hours at 4°C. Before imaging, antibody binding was detected using infrared-labeled goat anti-rabbit (green) at 1:10,000 dilutions for 1 hour at room temperature.
-
All lanes : Anti-MMP9 antibody [EP1254] (ab76003) at 5 µg
Lane 1 :Native human MMP9 protein (dimer) (ab168863)
Lane 2 :Native human MMP9 protein (Proenzyme, monomer) (ab157344)
Lane 3 :Recombinant Mouse MMP9 protein (ab39309)
Lysates/proteins at 0.1 µg per lane.
Secondary
All lanes : Infrared labeled goat anti-rabbit (green) antibody at 1/20000 dilution
Performed under reducing conditions.
Predicted band size: 78 kDaThis blot was produced using a 4-12% Bis-Tris gel under the MOPS buffer system. The gel was run at 200V for 60 minutes before being transferred onto a nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour before being incubated with anti-MMP9 antibody [EP1254] (ab76003; 5 microgram per mL) overnight at 4°C. Antibody binding was detected using infrared labeled goat anti-rabbit (green) antibody (diluted 1:20000) for 1 hour at room temperature before imaging.
-